Clinical Trials Browser

Completed × Breast Cancer Metastases × zirconium-89-trastuzumab × Clear all

NCT02286843 2021-06-18

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Phase NA Completed

49 enrolled 8 charts

Breast Cancer Metastases